Innovative radiotherapy offers a precision treatment alternative.

Palomar Health Foundation ignites youth interest in healthcare with Middle School Medical Discoveries program.

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

As clinical trials evolve, electronic Clinical Outcome Assessments (eCOA) remain central to data quality but often lag in adoption due to complex setup and deployment challenges. Tim Davis, vice ...